期刊文献+

透明质酸合成酶基因在甲状腺相关眼病患者和正常人眼眶结缔组织中的表达 被引量:4

Expression of hyaluronan synthase genes in orbital connective tissues of thyroid-associated ophthalmopathy patients and normal subjects
下载PDF
导出
摘要 目的探讨3种透明质酸合成酶基因(HAS)在甲状腺相关眼病(TAO)患者和正常人眼眶结缔组织中的表达。方法收集14例TAO患者(TAO组)和8例正常人(对照组)眼眶结缔组织标本,采用逆转录-聚合酶链式反应(RT-PCR)分别检测HAS1、HAS2和HAS3的mRNA表达水平。结果3种HAS基因mRNA在TAO患者和正常人眼眶结缔组织中的检出率相当,差异无显著性意义(P>0.05)。其中,HAS3在全部组织块中检出,HAS1在TAO组为64.3%,对照组为50%;HAS2在TAO组为21.4%,对照组为37.5%;TAO患者眼眶结缔组织HAS3基因表达量为正常人的4.5倍(P<0.01)。结论HAS1和HAS3基因mRNA在TAO患者眼眶结缔组织的大量表达,可能是TAO患者眼眶局部组织中透明质酸增加的分子基础。 Objective To measure the expression of hyaluronan synthase ( HAS) -1 ,-2, and -3 genes in the orbital connective tissues from the patients of thyroid-associated ophthalmopathy ( TAO ) and normal subjects. Methods The expression of HAS-1,-2, and -3 in the orbital tissues from 14 TAO patients and 8 normal subjects was measured by real-time PCR. Resutls HAS3 mRNA was detected by RT-PCR in all tissue blocks from TAO patients and normal subjects. HAS1 mRNA was detected in 9 blocks from the 14 patients,and 4 from the 8 normal subjects. HAS2 mRNA was detected in 2 blocks from the patients,and 3 from the controls. But the differences in the positive rates were not significant. The quantity of HAS3 mRNA copies in patients was 4. 5 times of the normal subjects, respectively( P 〈 0. 01 ). Conclusions Our observations suggest that the increased expression of the HAS genes in orbital connective tissue may be the molecular basis at least in part for the increased accumulation of hyaluronan in orbital connective tissue in TAO.
出处 《实用医院临床杂志》 2009年第5期28-30,共3页 Practical Journal of Clinical Medicine
关键词 甲状腺相关性眼病 透明质酸合成酶 基因 Hyaluronan synthase Thyroid-associated ophthalmopathy Gene
  • 相关文献

参考文献13

  • 1周晓红,罗清礼,夏瑞南.Graves眼病眼眶组织病理与IgA、IgE表达的研究[J].中华眼科杂志,1999,35(4):271-273. 被引量:14
  • 2Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties[ J ]. J Biol Chem, 1999, 274 ( 35 ) :25085-25092.
  • 3贺艳丽,张霞,凌沛学,张天民.玻璃酸的生理功能[J].中国生化药物杂志,2001,22(3):156-158. 被引量:5
  • 4Noble PW , Mckee CM , Cowman M ,et al. Hyaluronan fragments activate an NF-κB/I-Kκα autoregulatory loop in routine macrophages [ J ]. J Exp Med, 1996,183 (5) :2373 -2378.
  • 5Rooney P, Wang M, Kumar P,et al. Angiogenic oligosaccharides of hyalruonan enhance the production of collagens by endothelial cells[ J ]. J of Cell Sci, 1993, 105( 1 ) :213-218.
  • 6Termeer C, Hennies J, Voith V, et al. Oligosaeeharides of hyaluronan are potent activators of dentritie cells [ J ]. J Immunol, 2000,165 ( 4 ) : 1853- 1870.
  • 7Ialenti A , Di Rosa M. Hylauronic acid modulates acute and chronic inflammation [ J ]. Agents Actions, 1994,43 ( 1-2 ) :44-47.
  • 8Feinberg RN , Beebe DC. Hyalruonate in vasculogenesis[ J]. Secience, 1983,220 (4602) : 1177-1179.
  • 9Heldin P, Pertoft H. Synthesis and assembly of the hyaluronan-containing coats around human mesothelial cells [ J ]. Exp Cell Res, 1993, 208 (2) : 422-429.
  • 10Lee JY, Spicer AP. Hyaluronan: a muhifunctional, megaDalton, stealth molecule[J]. Current Opinion in Cell Biology,2000,12(5) :581-586.

二级参考文献15

  • 1Zeng C,Int J Cancer,1998年,77卷,396页
  • 2贺艳丽,杨晓红,王韶进,钱雪,凌沛学,张天民.玻璃酸钠抑制骨关节固定造成的兔膝关节退行性改变的实验研究[J].中国生化药物杂志,1997,18(1):12-15. 被引量:42
  • 3MysliwiecJetal. RockAkadMedBialymst . 1 999
  • 4SempowskiGDetal. American Journal of Physiology . 1 998
  • 5Cao HJ et al. American Journal of Physiology . 1999
  • 6McLachlan SM et al. The Journal of Clinical Endocrinology . 1994
  • 7Wang HS et al. Journal of Biological Chemistry . 1996
  • 8Young DA et al. Proceedings of the National Academy of Sciences of the United States of America . 1998
  • 9Elliott MJ et al. British Journal of Rheumatology . 1997
  • 10Bresnihan B et al. Arthritis and Rheumatism . 1998

共引文献23

同被引文献60

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部